참고문헌
- Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 2004;35:1200-7. https://doi.org/10.1016/j.bone.2004.07.004
- Yamamoto K, Yoshino S, Shue G, Nagashima M. Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. Rheumatol Int 2006;26:627-32. https://doi.org/10.1007/s00296-005-0042-y
- Suzuki Y, Aoki K, Saito H, Umeda M, Nitta H, Baron R, et al. A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice. J Periodontal Res 2006;41:81-91. https://doi.org/10.1111/j.1600-0765.2005.00812.x
- Benatti BB, Silve′rio KG, Casati MZ, Sallum EA, Nociti FH Jr. Inflammatory and bone-related genes are modulated by aging in human periodontal ligament cells. Cytokine 2009;46:176-81. https://doi.org/10.1016/j.cyto.2009.01.002
- Walsh NC, Crotti TN, Goldring SR, Gravallese EM. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 2005;208:228-51. https://doi.org/10.1111/j.0105-2896.2005.00338.x
- Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 1997;99:1699-703. https://doi.org/10.1172/JCI119333
- Lorenzo JA, Naprta A, Rao Y, Alander C, Glaccum M, Widmer M, et al. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 1998;139: 3022-5. https://doi.org/10.1210/en.139.6.3022
- Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor- alpha. J Biol Chem 2002;277:2695-701. https://doi.org/10.1074/jbc.M106339200
- Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, Detrano RC, et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 2003;100:11201-6. https://doi.org/10.1073/pnas.1932554100
- Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 2000;85:2907-12. https://doi.org/10.1210/jc.85.8.2907
- Mikami Y, Omoteyama K, Kato S, Takagi M. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells. Biochem Biophys Res Commun 2007;362:368-73. https://doi.org/10.1016/j.bbrc.2007.07.192
- Park BW, Byun JH, Lee SG, Hah YS, Kim DR, Cho YC, et al. Evaluation of osteogenic activity and mineralization of cultured human periosteal-derived cells. J Korean Assoc Maxillofac Plast Reconstr Surg 2006;28:511-9.
- Park BW, Byun JH, Ryu YM, Hah YS, Kim DR, Cho YC, et al. Correlation between vascular endothelial growth factor signaling and mineralization during osteoblastic differentiation of cultured human periosteal-derived cells. J Korean Assoc Maxillofac Plast Reconstr Surg 2007;29:197-205.
- Walsh NC, Gravallese EM. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 2010;233:301-12. https://doi.org/10.1111/j.0105-2896.2009.00857.x
- Li YP, Stashenko P. Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter. J Immunol 1992;148:788-94.
- Panagakos FS, Hinojosa LP, Kumar S. Formation and mineralization of extracellular matrix secreted by an immortal human osteoblastic cell line: modulation by tumor necrosis factor-alpha. Inflammation 1994;18:267-84. https://doi.org/10.1007/BF01534268
- Nanes MS. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1-15. https://doi.org/10.1016/S0378-1119(03)00841-2
- Segal B, Rhodus NL, Patel K. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:778-87. https://doi.org/10.1016/j.tripleo.2008.07.025
- Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 2002;196:77-85. https://doi.org/10.1084/jem.20020439
- Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005;115: 282-90.
- Zwerina J, Redlich K, Polzer K, Joosten L, Kronke G, Distler J. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 2007;104:11742-7. https://doi.org/10.1073/pnas.0610812104